Loading
·
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.
The quarterly reports for this company are not available yet. Please check back later.
In the mean time, check out some related stocks.